Lansdale, PA, United States of America

Kodumudi S Balaji

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 3.3

ph-index = 4

Forward Citations = 57(Granted Patents)


Location History:

  • Downingtown, PA (US) (2016)
  • Landsdale, PA (US) (2015 - 2020)
  • Lansdale, PA (US) (2012 - 2022)

Company Filing History:


Years Active: 2012-2022

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents

Title: Innovations by Kodumudi S Balaji in Pharmaceutical Patents

Introduction

Kodumudi S Balaji, based in Lansdale, PA, has made significant contributions to the field of pharmaceuticals, holding a total of 12 patents. His work primarily focuses on developing innovative treatment methods for skin conditions and bacterial infections, enhancing patient care through effective drug delivery systems.

Latest Patents

Among his notable patents, Balaji has developed a 2x2x2 week dosing regimen for treating actinic keratosis. This innovative regimen employs pharmaceutical compositions formulated with 3.75% imiquimod. His inventions also include novel pharmaceutical formulations for the topical or transdermal delivery of imiquimod, targeting actinic keratosis with shorter and more convenient therapy durations than currently prescribed treatments, such as Aldara® 5% imiquimod cream. Another significant innovation involves aqueous-based metronidazole gel formulations, specifically designed for intravaginal applications to effectively treat bacterial vaginosis. These formulations boast an improved safety profile and ease of use, making them a valuable addition to current therapeutic options.

Career Highlights

Throughout his career, Kodumudi S Balaji has been associated with leading pharmaceutical companies, including Medicis Pharmaceutical Corporation and Chemo Research, S.L. His extensive experience in these roles has allowed him to contribute towards the advancement of effective medical treatments, focusing on innovative drug formulations and delivery methods.

Collaborations

Balaji has collaborated with prominent professionals in the industry, including Michael T Nordsiek and Sharon F Levy. These partnerships have facilitated knowledge exchange and fostered the development of groundbreaking solutions in pharmaceuticals.

Conclusion

Kodumudi S Balaji's innovative approach to pharmaceutical formulations has greatly impacted the treatment of various conditions. With his robust portfolio of patents and collaborations with esteemed colleagues, Balaji continues to pave the way for advancements in the medical field, ultimately improving patient outcomes and therapeutic efficacy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…